Ntrans Technologies Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $2.43M

  • Investors
  • 8

Ntrans Technologies General Information

Description

Operator of a biotech company intended to develop a proprietary platform for the intracellular delivery of bioactive molecules. The company's platform provides intracellular delivery technology that transduces proteins, peptides, nanobodies, and small oligonucleotides into patients' cells, where they can perform specific tasks to correct the patient's disease, enabling the research community to develop therapies for the treatment of genetic diseases and cancer.

Contact Information

Website
www.ntranstechnologies.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Biopartner/BP2
  • J.H. Oortweg 19
  • 2333 CH Leiden
  • Netherlands
+31 071
Primary Industry
Drug Delivery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Biopartner/BP2
  • J.H. Oortweg 19
  • 2333 CH Leiden
  • Netherlands
+31 071

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ntrans Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series A) 27-May-2021 $2.43M Completed Generating Revenue
1. Grant 04-Sep-2017 Completed Startup
To view Ntrans Technologies’s complete valuation and funding history, request access »

Ntrans Technologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotech company intended to develop a proprietary platform for the intracellular delivery of bioactive mol
Drug Delivery
Leiden, Netherlands
6 As of 2025

Cambridge, MA
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ntrans Technologies Competitors (2)

One of Ntrans Technologies’s 2 competitors is Sarepta Therapeutics, a Formerly VC-backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sarepta Therapeutics Formerly VC-backed Cambridge, MA
Pfizer Corporation New York, NY
You’re viewing 2 of 2 competitors. Get the full list »

Ntrans Technologies Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 3

    Pending

  • Expiring in next 12 mo

Ntrans Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3223346-A1 Transduction buffer Pending 07-Jul-2021
EP-4367254-A1 Transduction buffer Pending 07-Jul-2021
US-20240307554-A1 Transduction buffer Pending 07-Jul-2021
WO-2023281026-A1 Transduction buffer Inactive 07-Jul-2021 C12N15/87

Ntrans Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ntrans Technologies Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Blue Ocean Capital (Netherlands) Venture Capital Minority
BOP Impact Ventures PE/Buyout Minority
Essential Investments Asset Manager Minority
Mibiton Venture Capital Minority
Starfish Innovation Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Ntrans Technologies FAQs

  • When was Ntrans Technologies founded?

    Ntrans Technologies was founded in 2015.

  • Where is Ntrans Technologies headquartered?

    Ntrans Technologies is headquartered in Leiden, Netherlands.

  • What is the size of Ntrans Technologies?

    Ntrans Technologies has 6 total employees.

  • What industry is Ntrans Technologies in?

    Ntrans Technologies’s primary industry is Drug Delivery.

  • Is Ntrans Technologies a private or public company?

    Ntrans Technologies is a Private company.

  • What is Ntrans Technologies’s current revenue?

    The current revenue for Ntrans Technologies is .

  • How much funding has Ntrans Technologies raised over time?

    Ntrans Technologies has raised $2.43M.

  • Who are Ntrans Technologies’s investors?

    Blue Ocean Capital (Netherlands), BOP Impact Ventures, Essential Investments, Mibiton, and Starfish Innovation are 5 of 8 investors who have invested in Ntrans Technologies.

  • Who are Ntrans Technologies’s competitors?

    Sarepta Therapeutics and Pfizer are competitors of Ntrans Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process